e-ISSN 2148-0532 DOI 10.54233 Open Access · CC BY-NC-SA 4.0 Türkçe
Endoüroloji Bülteni — Endourology Bulletin Submit Manuscript
Original Article Open Access

Association Between Comorbidity Burden and Tissue-Adjusted Enucleation Time During HoLEP: A Retrospective Cohort Study

HoLEP Sırasında Komorbidite Yükü ile Doku Yüküne Göre Düzeltilmiş Enükleasyon Süresi Arasındaki İlişki: Retrospektif Kohort Çalışması

Author information
  1. University of Health Sciences, İstanbul Kartal Dr. Lütfi Kirdar Health Research Center, Department of Surgical Medical Sciences, The Department of Urology
Issue
Volume 18 · Issue 3
Pages
160-175
Published
September 30, 2026
DOI
https://doi.org/10.54233/endourolbull-1898671 (opens in a new tab)

Abstract

Objective: To quantify phase-specific operative performance during holmium laser enucleation of the prostate (HoLEP) and evaluate the association between comorbidity burden and tissue-adjusted enucleation performance.

Materials and Methods: This single-center retrospective cohort screened 574 HoLEP procedures performed between January 2023 and June 2025 and included 349 patients. Enucleation efficiency (g/min), morcellation efficiency, and overall extraction efficiency were calculated descriptively. To avoid mathematical coupling, the primary inferential analysis modeled natural log-transformed enucleation time and adjusted for age, log-transformed enucleated tissue weight, prostate-volume stratum, and antithrombotic use. Heteroscedasticity-consistent HC3 standard errors were used.

Results: Median age was 67 years, and 67.9% had at least one comorbidity. Unadjusted enucleation time was similar in patients without and with comorbidity (41.5 vs 42.0 min; p = 0.337), whereas enucleation efficiency was lower in those with comorbidity (0.93 vs 1.75 g/min; p < 0.001). In the adjusted model, each additional comorbidity was associated with a 9.9% longer enucleation time for a given tissue burden (95% CI: 4.8%-15.2%; p < 0.001; adjusted R²=0.167). The association persisted after additional adjustment for operative technique category (8.0%; 95% CI: 4.5%-11.6%; p < 0.001). Antithrombotic use was not independently associated with enucleation time.

Conclusion: Comorbidity burden was associated with slower tissue-adjusted enucleation performance despite similar unadjusted enucleation times. Total operating-room occupancy was not assessed. These hypothesis-generating findings require multicenter validation with operator-level, anesthetic, and intraoperative bleeding data before use in scheduling or benchmarking.

More From This Issue